Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 25:47:101114.
doi: 10.1016/j.lanepe.2024.101114. eCollection 2024 Dec.

Monkeypox clade IIb in France in 2023-2024

Mayda Rahi  1 , Sebastien Fouere  2 , Marie Gilbert  1 , Antoine Bachelard  1 , Fabien Taieb  3 , Baptiste Sellem  4 , Florian Herms  2 , Charles Cazanave  5 , Nadia Valin  6 , Gentiane Monsel  4 , Yazdan Yazdanpanah  1   7 , Jade Ghosn  1   7 , Nathan Peiffer-Smadja  1   7 ; MPV 23-24 Study group
Collaborators, Affiliations

Monkeypox clade IIb in France in 2023-2024

Mayda Rahi et al. Lancet Reg Health Eur. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no conflict of interests.

Figures

Fig. 1
Fig. 1
Timeline of vaccination in relation to date of mpox diagnosis among those vaccinated in the reported group. ∗ MVA-BN, Third-generation smallpox vaccine.
See this image and copyright information in PMC

References

    1. Ferré V.M., Bachelard A., Zaidi M., et al. Detection of monkeypox virus in anorectal swabs from asymptomatic men who have sex with men in a sexually transmitted infection screening program in Paris, France. Ann Intern Med. 2022;175(10):1491–1492. doi: 10.7326/M22-2183. - DOI - PubMed
    1. Thy M., Peiffer-Smadja N., Mailhe M., et al. Breakthrough infections after postexposure vaccination against mpox. N Engl J Med. 2022;387(26):2477–2479. doi: 10.1056/NEJMc2211944. - DOI - PubMed
    1. Deputy N.P., Deckert J., Chard A.N., et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med. 2023;388(26):2434–2443. doi: 10.1056/NEJMoa2215201. - DOI - PMC - PubMed
    1. Ghosn J., Assoumou L., Ouattara M., et al. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. Lancet Reg Health Eur. 2024;45 - PMC - PubMed
    1. Griffin I., Berry I., Navarra T., et al. Serologic responses to the MVA-based JYNNEOS mpox vaccine in a cohort of participants from the District of Columbia (D.C.) Vaccine. 2024;42(19):4056–4065. doi: 10.1016/j.vaccine.2024.05.017. - DOI - PubMed

LinkOut - more resources